Stock comparison
JOHNSON & JOHNSON is 26.4x more valuable than Roivant Sciences Ltd. by market capitalization ($663.28 B vs $25.12 B). Compare market value, revenue, profit, margins, filings, and source pages in one place.
Quick answer
JNJ is larger
JOHNSON & JOHNSON is 26.4x more valuable than Roivant Sciences Ltd. by market capitalization ($663.28 B vs $25.12 B).
Market value leader
JNJ
JOHNSON & JOHNSON is 26.4x more valuable than Roivant Sciences Ltd. by market capitalization ($663.28 B vs $25.12 B).
Revenue leader
JNJ
ROIV: $8.26M vs JNJ: $94.19B.
Profit leader
JNJ
ROIV: -$299.77M vs JNJ: $26.80B.
Margin leader
JNJ
ROIV: -3629.2% vs JNJ: 28.5% net margin.
| Metric | ROIV | JNJ |
|---|---|---|
| Market cap | $25.12 B | $663.28 B |
| US-listed rank | #536 | #16 |
| Revenue (latest FY) | $8.26M | $94.19B |
| Net income (latest FY) | -$299.77M | $26.80B |
| Net margin | -3629.2% | 28.5% |
| P/E (trailing FY) | - | 24.7x |
| SEC filings | 868 | 990 |
Jump from this comparison into the underlying pages for market value, annual fundamentals, and company filing history.
Market cap uses refreshed market data. Revenue, net income, margins, and trailing fiscal-year P/E use annual company facts from filings. If a metric is missing, the source data did not have a clean recent annual value for that company.
JOHNSON & JOHNSON is 26.4x more valuable than Roivant Sciences Ltd. by market capitalization ($663.28 B vs $25.12 B).
In their latest fiscal years, Roivant Sciences Ltd. reported $8.26M in revenue while JOHNSON & JOHNSON reported $94.19B.
Full pages: Roivant Sciences Ltd. and JOHNSON & JOHNSON, or browse the full rankings.